Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural... see more

GREY:ISCNF - Post Discussion

Isracann Biosciences Inc > Future Value of IPOT
View:
Post by BossHog19 on Dec 04, 2020 12:22pm

Future Value of IPOT

Their facilities have the capacity to produce  $273 million/year. With a  market cap of 42 million that works out to earnings of $6.50/share, with a PE of 10 that would put the stock value at $65/share. On top of that the company is expanding its facilites. They also claim to be cost competitive claiming the cost to grow in Israel is as low as one third the cost of production in colder climates.  And yes I am invested in this stock.
Comment by BossHog19 on Dec 04, 2020 2:14pm
Correction: I just talked to my broker, there are 105 million shares of Isracann, not 41.9 million shares that stockhouse.com has posted. This would put the future value limit to $26
Comment by guerreiro on Dec 04, 2020 7:55pm
Nice close today, this baby is preparing for a home run. Will it go over $1 before 2021.
Comment by guerreiro on Dec 08, 2020 2:20am
Options were approved for insiders today at .32 cents. That is possible why they were holding the stock back. Filing DateTransaction DateInsider NameOwnership TypeSecuritiesNature of transactionVolume or ValuePriceDec 7/20Dec 7/20Bromley, SeanDirect OwnershipOptions50 - Grant of options300,000$0.320 Dec 7/20Dec 7/20Arbel, IritDirect OwnershipOptions50 - Grant of options100,000$0.320 Dec 7/20Dec ...more  
Comment by guerreiro on Dec 18, 2020 3:04pm
Look at Level 2 bid support level.  The stock is going through the accumulation stage. It's just a matter of time we will have a home run. It's a waiting game for now as things are coming together.
Comment by guerreiro on Dec 18, 2020 3:11pm
  Level ll Quote   Bid   Ask   Price   Total Size   # of Orders   Price   Total Size   # of Orders $0.295 90500 3 $0.30 4000 1 $0.29 20000 1  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities